Author： Crul M. Rosing H. de Klerk G.J. Dubbelman R. Traiser M. Reichert S. Knebel N.G. Schellens J.H.M. Beijnen J.H. ten Bokkel Huinink W.W.
Publisher： Elsevier
ISSN： 0959-8049
Source： European Journal of Cancer, Vol.38, Iss.12, 2002-08, pp. : 1615-1621
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Awada A. Eskens F.A.L.M. Piccart M. Cutler D.L. van der Gaast A. Bleiberg H. Wanders J. Faber M.N. Statkevich P. Fumoleau P. Verweij J. for the EORTC Early Clinical Studies Group
European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. :
Access to resources
Recommend
By Gerrits C.J.H. Burris H. Schellens J.H.M. Planting A.S.T. van den Burg M.E.L. Rodriguez G.I. van Beurden V. Loos W.J. Hudson I. Fields S. Verweij J. von Hoff D.D.
European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. :
By Eskens F.A.L.M. Dumez H. Hoekstra R. Perschl A. Brindley C. Bottcher S. Wynendaele W. Drevs J. Verweij J. van Oosterom A.T.
European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. :
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours
By Androulakis N. Kouroussis C. Mavroudis D. Kakolyris S. Souglakos J. Agelaki S. Kalbakis K. Malas K. Pallis A. Samonis G. Georgoulias V.
European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. :